Advanced
  Home Compare Reports

Comparison with Similar Reports

Sleep Apnea Devices Market by Type,Therapeutic (PAP (CPAP, APAP, BPAP) Facial Interfaces,Oral Appliances, Accessories), Diagnostic (PSG, Oximeter, Act...

Publisher:       

# of Pages:        315

Rating: 

1 User License $4,950

Publication Date:  August, 2021

Price:       $4,950 / User License




1 INTRODUCTION 38
1.1 OBJECTIVES OF THE STUDY 38
1.2 MARKET DEFINITION 38
TABLE 1 INCLUSIONS & EXCLUSIONS OF THE STUDY 39
1.3 MARKET SEGMENTATION 40
1.3.1 MARKETS COVERED 40
FIGURE 1 SLEEP APNEA DEVICES MARKET SEGMENTATION 40
1.3.2 YEARS CONSIDERED FOR THE STUDY 41
1.4 CURRENCY 41
TABLE 2 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD 41
1.5 STAKEHOLDERS 42
1.6 SUMMARY OF CHANGES 42
2 RESEARCH METHODOLOGY 44
2.1 RESEARCH DATA 44
FIGURE 2 SLEEP APNEA DEVICES MARKET: RESEARCH DESIGN 44
2.1.1 SECONDARY DATA 45
2.1.1.1 Key data from secondary sources 46
2.1.2 PRIMARY DATA 46
FIGURE 3 PRIMARY SOURCES 47
2.1.2.1 Key data from primary sources 48
2.1.2.2 Key industry insights 49
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 49
2.2 MARKET SIZE ESTIMATION 50
FIGURE 5 SLEEP APNEA DEVICES MARKET – REVENUE SHARE ANALYSIS ILLUSTRATION: RESMED 51
FIGURE 6 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF SLEEP APNEA DEVICES 51
FIGURE 7 CAGR PROJECTIONS 53
FIGURE 8 TOP-DOWN APPROACH 54
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 54
2.3.1 SECONDARY DATA 54
2.3.2 PRIMARY DATA 55
FIGURE 9 DATA TRIANGULATION METHODOLOGY 56
2.4 MARKET SHARE ANALYSIS 56
2.5 ASSUMPTIONS FOR THE STUDY 57
2.6 INDICATORS AND ASSUMPTIONS AND THEIR IMPACT ON THE STUDY 57
2.6.1 COVID-19-SPECIFIC ASSUMPTIONS 58
2.7 LIMITATIONS 58
2.8 RISK ASSESSMENT 59
TABLE 3 RISK ASSESSMENT 59
2.9 COVID-19 ECONOMIC ASSESSMENT 59
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 59
FIGURE 10 CRITERIA IMPACTING THE GLOBAL ECONOMY 60
FIGURE 11 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 61
3 EXECUTIVE SUMMARY 62
FIGURE 12 SLEEP APNEA DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION) 62
FIGURE 13 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2021 VS. 2026 (USD BILLION) 63
FIGURE 14 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2021 VS. 2026 (USD BILLION) 64
FIGURE 15 SLEEP APNEA DEVICES MARKET, BY END USER,
2021 VS. 2026 (USD BILLION) 64
FIGURE 16 GEOGRAPHICAL SNAPSHOT OF THE SLEEP APNEA DEVICES MARKET 65
4 PREMIUM INSIGHTS 67
4.1 SLEEP APNEA DEVICES MARKET OVERVIEW 67
FIGURE 17 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS TO DRIVE
THE MARKET FOR SLEEP APNEA DEVICES 67
4.2 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY TYPE (2020) 68
FIGURE 18 THERAPEUTIC DEVICES WILL CONTINUE TO DOMINATE THE ASIA PACIFIC SLEEP APNEA DEVICES MARKET IN 2020 68
4.3 SLEEP APNEA DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 69
FIGURE 19 CHINA TO REGISTER THE HIGHEST REVENUE GROWTH DURING
THE FORECAST PERIOD 69
4.4 SLEEP APNEA DEVICES MARKET, BY REGION (2019–2026) 70
FIGURE 20 NORTH AMERICA WILL CONTINUE TO DOMINATE THE SLEEP APNEA DEVICES MARKET DURING THE FORECAST PERIOD 70
4.5 SLEEP APNEA DEVICES MARKET: DEVELOPED VS. DEVELOPING MARKETS 70
FIGURE 21 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING
THE FORECAST PERIOD 70
5 MARKET OVERVIEW 71
5.1 INTRODUCTION 71
5.2 MARKET DYNAMICS 71
TABLE 4 MARKET DYNAMICS: SLEEP APNEA DEVICES MARKET 72
5.2.1 DRIVERS 72
5.2.1.1 Large pool of undiagnosed sleep apnea patients 72
TABLE 5 GLOBAL PREVALENCE OF SLEEP APNEA IN 2019 73
TABLE 6 PREVALENCE OF SLEEP APNEA IN EUROPEAN COUNTRIES 74
5.2.1.2 Favorable reimbursements and financial aid for sleep apnea devices and therapies 75
TABLE 7 REIMBURSEMENT CODES AND COSTS OF SOME SLEEP APNEA DEVICES BY RESMED 75
TABLE 8 ESTABLISHED CPT CODES PROVIDED BY ITAMAR MEDICAL 76
5.2.1.3 Growing awareness about the ill effects of untreated sleep apnea 77
TABLE 9 INITIATIVES TO PROMOTE AWARENESS ABOUT THE ILL EFFECTS OF UNTREATED SLEEP APNEA 77
5.2.1.4 Growing usage of oral appliances 78
TABLE 10 LIST OF ADVANCED ORAL APPLIANCES AVAILABLE FOR THE TREATMENT OF SLEEP APNEA 79
5.2.1.5 Increasing number of companies venturing into the sleep apnea devices and oral appliances markets 79
5.2.2 RESTRAINTS 80
5.2.2.1 High cost of CPAP machines 80
5.2.2.2 Complex referral pathways, long waiting periods, and product recalls 80
5.2.3 OPPORTUNITIES 81
5.2.3.1 Growing demand for home sleep apnea tests (HSATs) 81
5.2.3.2 Increasing focus on telemedicine, mHealth (mobile health), and artificial intelligence 82
5.2.4 CHALLENGES 83
5.2.4.1 Lack of patient compliance 83
5.3 COVID-19 IMPACT ON THE SLEEP APNEA DEVICES MARKET 83
FIGURE 22 COVID-19 IMPACT ON IN-FACILITY PATIENTS OF SLEEP APNEA 84
FIGURE 23 SLEEP CARE DELIVERY DURING COVID-19 84
FIGURE 24 SLEEP TESTING DURING THE COVID-19 85
TABLE 11 COVID-19 IMPACT ON THE SLEEP APNEA DEVICES MARKET 85
FIGURE 25 COVID-19 IMPACT ON THE REVENUES OF KEY PLAYERS’ SLEEP APNEA DEVICE BUSINESSES 86
5.4 REGULATORY ANALYSIS 87
TABLE 12 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THE SLEEP APNEA DEVICES MARKET 87
5.4.1 NORTH AMERICA 88
5.4.1.1 US 88
TABLE 13 US FDA: MEDICAL DEVICE CLASSIFICATION 89
TABLE 14 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 89
5.4.1.2 Canada 90
TABLE 15 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 90
FIGURE 26 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 91
5.4.2 EUROPE 91
FIGURE 27 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR) 93
5.4.3 ASIA PACIFIC 93
5.4.3.1 Japan 93
5.4.3.1.1 Revision of the Pharmaceutical Affairs Law (PAL) and implementation of the new PMD Act in Japan 94
TABLE 16 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 95
5.4.3.2 China 95
TABLE 17 CHINA: CLASSIFICATION OF MEDICAL DEVICES 96
5.4.3.3 India 97
5.4.3.4 Australia 97
5.4.3.4.1 TGA device classification 98
5.5 TECHNOLOGY ANALYSIS 99
TABLE 18 RECENT TECHNOLOGICAL ADVANCEMENTS IN SLEEP APNEA DEVICES 99
5.6 PRICING ANALYSIS 100
TABLE 19 AVERAGE SELLING PRICES OF POSITIVE AIRWAY PRESSURE DEVICES 100
TABLE 20 AVERAGE SELLING PRICES OF FACIAL INTERFACES 101
TABLE 21 COST OF SLEEP APNEA TESTING 101
5.7 TRADE ANALYSIS 101
5.7.1 IMPORT DATA FOR HS CODE 901890, BY COUNTRY,
2016–2020 (USD MILLION) 102
5.7.2 EXPORT DATA FOR HS CODE 901890, BY COUNTRY,
2016–2020 (USD MILLION) 102
5.8 PATENT ANALYSIS 103
FIGURE 28 LIST OF MAJOR PATENTS FOR SLEEP APNEA DEVICES 103
FIGURE 29 REGIONAL ANALYSIS OF PATENTS GRANTED FOR THE SLEEP APNEA DEVICES MARKET, 2015–2021 104
TABLE 22 INDICATIVE LIST OF SLEEP APNEA DEVICE PATENTS 104
5.9 VALUE CHAIN ANALYSIS 109
FIGURE 30 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING
THE MANUFACTURING AND ASSEMBLY PHASES 109
5.10 SUPPLY CHAIN ANALYSIS 110
FIGURE 31 DIRECT DISTRIBUTION—THE PREFERRED STRATEGY OF PROMINENT COMPANIES 111
5.11 ECOSYSTEM ANALYSIS 111
FIGURE 32 SLEEP APNEA DEVICES MARKET: ECOSYSTEM ANALYSIS 111
5.11.1 ROLE IN THE ECOSYSTEM 112
FIGURE 33 KEY PLAYERS IN THE SLEEP APNEA DEVICES MARKET ECOSYSTEM 112
5.12 PORTER’S FIVE FORCES ANALYSIS 113
5.12.1 THREAT FROM NEW ENTRANTS 113
5.12.2 BARGAINING POWER OF SUPPLIERS 113
5.12.3 BARGAINING POWER OF BUYERS 113
5.12.4 INTENSITY OF COMPETITIVE RIVALRY 114
5.12.5 THREAT FROM SUBSTITUTES 114
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 114
5.13.1 REVENUE SHIFT AND REVENUE POCKETS FOR SLEEP APNEA DEVICE MANUFACTURERS 114
5.13.2 REVENUE SHIFT FOR SLEEP APNEA DEVICES 115
5.14 RANGES/SCENARIOS 115
5.14.1 PESSIMISTIC SCENARIO OF THE SLEEP APNEA DEVICES MARKET 115
5.14.2 REALISTIC SCENARIO OF THE SLEEP APNEA DEVICES MARKET 116
5.14.3 OPTIMISTIC SCENARIO OF THE SLEEP APNEA DEVICES MARKET 116
6 EPIDEMIOLOGICAL ASSESSMENT OF SLEEP APNEA 117
6.1 INTRODUCTION 117
6.2 EPIDEMIOLOGICAL ASSESSMENT 117
FIGURE 34 TOP TEN COUNTRIES WITH THE HIGHEST ESTIMATED NUMBER OF INDIVIDUALS WITH OBSTRUCTIVE SLEEP APNOEA BASED ON THE AMERICAN ACADEMY OF SLEEP MEDICINE 2012 CRITERIA 118
6.3 PRESCRIPTION PATTERN ASSESSMENT 119
6.4 ADHERENCE ASSESSMENT 120
7 ALTERNATE THERAPIES FOR SLEEP APNEA 122
7.1 INTRODUCTION 122
7.2 EXPIRATORY POSITIVE AIRWAY PRESSURE 122
7.3 HYPOGLOSSAL NERVE STIMULATION 122
7.4 ORAL PRESSURE THERAPY (OPT) 123
7.5 POSITIONAL THERAPY 123
8 SLEEP APNEA DEVICES MARKET, BY TYPE 125
8.1 INTRODUCTION 126
TABLE 23 SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 126
8.2 THERAPEUTIC DEVICES 126
TABLE 24 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 126
TABLE 25 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 127
8.2.1 POSITIVE AIRWAY PRESSURE DEVICES 127
TABLE 26 PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 127
TABLE 27 PAP DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 128
8.2.1.1 Continuous positive airway pressure devices 128
8.2.1.1.1 CPAP devices are considered the gold standard in sleep apnea treatment—a key factor driving market growth 128
TABLE 28 CPAP DEVICES OFFERED BY KEY PLAYERS 129
TABLE 29 CPAP DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 130
8.2.1.2 Automatic positive airway pressure devices 130
8.2.1.2.1 Demand for APAP devices has increased significantly in
the last few years due to patient non-compliance with CPAP devices 130
TABLE 30 APAP DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 131
8.2.1.3 Bilevel positive airway pressure devices 131
8.2.1.3.1 BPAP devices are generally costlier and more complex than other available PAP devices, which is a major reason for their low adoption 131
TABLE 31 BPAP DEVICES OFFERED BY KEY PLAYERS 132
TABLE 32 BPAP DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 133
8.2.2 FACIAL INTERFACES 133
TABLE 33 FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION) 133
TABLE 34 FACIAL INTERFACES MARKET, BY REGION, 2019–2026 (USD MILLION) 134
8.2.2.1 Masks 134
TABLE 35 MASKS OFFERED BY KEY PLAYERS 134
TABLE 36 MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 136
TABLE 37 MASKS MARKET, BY REGION, 2019–2026 (USD MILLION) 136
8.2.2.1.1 Full-face masks 136
8.2.2.1.1.1 Full-face masks offer the greatest chance of compliance for mouth breathers or patients who struggle to breathe through their nose 136
TABLE 38 FULL-FACE MASKS OFFERED BY KEY PLAYERS 137
TABLE 39 FULL-FACE MASKS MARKET, BY REGION, 2019–2026 (USD MILLION) 137
8.2.2.1.2 Nasal pillow masks 138
8.2.2.1.2.1 Greater patient compliance is one of the key factors driving the demand for nasal pillow masks 138
TABLE 40 NASAL PILLOW MASKS OFFERED BY KEY PLAYERS 138
TABLE 41 NASAL PILLOW MASKS MARKET, BY REGION, 2019–2026 (USD MILLION) 139
8.2.2.1.3 Nasal masks 139
8.2.2.1.3.1 Nasal masks have an advantage over full-face masks in that they do not obstruct the patients’ view and allow patients to wear spectacles 139
TABLE 42 NASAL MASKS MARKET, BY REGION, 2019–2026 (USD MILLION) 139
8.2.2.2 Cushions 140
8.2.2.2.1 Different product launches in the past few years to drive market growth 140
TABLE 43 CUSHIONS OFFERED BY KEY PLAYERS 140
TABLE 44 CUSHIONS MARKET, BY REGION, 2019–2026 (USD MILLION) 140
8.2.3 ACCESSORIES 141
TABLE 45 ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 141
TABLE 46 ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION) 141
8.2.3.1 Humidifier accessories 142
8.2.3.1.1 Humidifiers help to open the airways, decrease congestion, and encourage clearer breathing 142
TABLE 47 HUMIDIFIER ACCESSORIES MARKET, BY REGION,
2019–2026 (USD MILLION) 142
8.2.3.2 Power accessories 142
8.2.3.2.1 Power accessories help to manage uninterrupted sleep apnea therapy in the absence of a power supply 142
TABLE 48 POWER ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION) 143
8.2.3.3 Transportation accessories 143
8.2.3.3.1 The convenience associated with transportation accessories to drive market growth 143
TABLE 49 TRANSPORTATION ACCESSORIES MARKET, BY REGION,
2019–2026 (USD MILLION) 143
8.2.3.4 Communication accessories 144
8.2.3.4.1 Communication accessories help monitor sleep apnea symptoms through teleconsultations 144
TABLE 50 COMMUNICATION ACCESSORIES MARKET, BY REGION,
2019–2026 (USD MILLION) 144
8.2.3.5 Chin restraints 144
8.2.3.5.1 Chin restraints hold the mouth in position during therapy— an essential part of sleep apnea management 144
TABLE 51 CHIN RESTRAINTS MARKET, BY REGION, 2019–2026 (USD MILLION) 145
8.2.3.6 Other accessories 145
TABLE 52 OTHER ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION) 145
8.2.4 ORAL APPLIANCES 146
TABLE 53 ORAL APPLIANCES OFFERED BY KEY PLAYERS 146
TABLE 54 ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION) 147
TABLE 55 ORAL APPLIANCES MARKET, BY REGION, 2019–2026 (USD MILLION) 147
8.2.4.1 Mandibular advancement devices 147
8.2.4.1.1 Mandibular advancement devices are primarily used for the treatment of mild OSA and snoring 147
TABLE 56 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 148
8.2.4.2 Tongue-retaining devices 148
8.2.4.2.1 TRDs are less expensive and help reduce both snoring and sleep apnea 148
TABLE 57 TONGUE-RETAINING DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 148
8.2.5 ADAPTIVE SERVO-VENTILATORS 149
8.2.5.1 Improving clinical outcomes associated with ASVs to fuel market growth 149
TABLE 58 ADAPTIVE SERVO-VENTILATORS MARKET, BY REGION,
2019–2026 (USD MILLION) 149
8.2.6 OTHER THERAPEUTIC DEVICES 150
TABLE 59 OTHER THERAPEUTIC DEVICES OFFERED BY THE KEY PLAYERS 150
TABLE 60 OTHER THERAPEUTIC DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 151
8.3 DIAGNOSTIC DEVICES 151
TABLE 61 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 151
TABLE 62 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 152
8.3.1 POLYSOMNOGRAPHY DEVICES 152
TABLE 63 PSG DEVICES OFFERED BY KEY PLAYERS 152
TABLE 64 PSG DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 153
TABLE 65 PSG DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 153
8.3.1.1 Ambulatory PSG devices 153
8.3.1.1.1 The demand for ambulatory PSG devices has increased due to their cost-effectiveness and convenience for patients 153
TABLE 66 AMBULATORY PSG DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 154
8.3.1.2 Clinical PSG devices 154
8.3.1.2.1 These devices require constant supervision—a key factor limiting market growth 154
TABLE 67 CLINICAL PSG DEVICES OFFERED BY KEY PLAYERS 154
TABLE 68 CLINICAL PSG DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION) 155
8.3.2 HOME SLEEP TESTING DEVICES 155
8.3.2.1 Cost-effectiveness and comfort of home sleep testing are expected to drive the growth of home sleep testing devices 155
TABLE 69 HOME SLEEP TESTING DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 156
8.3.3 OXIMETERS 156
TABLE 70 OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 156
TABLE 71 OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION) 157
8.3.3.1 Fingertip oximeters 157
8.3.3.1.1 A major drawback of fingertip oximeters is that they cannot provide precise readings if the patient’s hand is injured or if there is slow blood flow due to blood clotting or any injury 157
TABLE 72 FINGERTIP OXIMETERS OFFERED BY KEY PLAYERS 157
TABLE 73 FINGERTIP OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION) 158
8.3.3.2 Handheld oximeters 158
8.3.3.2.1 Handheld oximeters are more expensive than fingertip and wrist oximeters 158
TABLE 74 HANDHELD OXIMETERS OFFERED BY KEY PLAYERS 158
TABLE 75 HANDHELD OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION) 159
8.3.3.3 Wrist-worn oximeters 159
8.3.3.3.1 The global demand for wrist-worn oximeters is propelled by their small size, long-term usage, need for overnight monitoring, and their portability 159
TABLE 76 WRIST-WORN OXIMETERS OFFERED BY KEY PLAYERS 159
TABLE 77 WRIST-WORN OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION) 160
8.3.3.4 Tabletop oximeters 160
8.3.3.4.1 Tabletop oximeters account for a smaller share of the market than handheld or wrist-worn oximeters due to their higher cost and fewer applications 160
TABLE 78 TABLETOP OXIMETERS OFFERED BY KEY PLAYERS 160
TABLE 79 TABLETOP OXIMETERS MARKET, BY REGION, 2019–2026 (USD MILLION) 161
8.3.4 ACTIGRAPHY SYSTEMS 161
8.3.4.1 Increasing focus on assessing actimeter performance contributes to market growth 161
TABLE 80 ACTIGRAPHY SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION) 162
8.3.5 SLEEP SCREENING DEVICES 162
8.3.5.1 Increasing preference for home-based testing for its efficacy and comfort are driving the use of sleep screening devices 162
TABLE 81 SLEEP SCREENING DEVICES OFFERED BY KEY PLAYERS 162
TABLE 82 SLEEP SCREENING DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION) 163
9 SLEEP APNEA DEVICES MARKET, BY END USER 164
9.1 INTRODUCTION 165
TABLE 83 SLEEP APNEA DEVICES MARKET, BY END USER, 2019–2026 (USD MILLION) 165
9.2 SLEEP LABORATORIES & HOSPITALS 165
9.2.1 ADVANCED INFRASTRUCTURE AND EXPENDITURE OF SLEEP LABORATORIES & HOSPITALS TO DRIVE GROWTH IN THIS END-USER SEGMENT 165
TABLE 84 SLEEP APNEA DEVICES MARKET FOR SLEEP LABORATORIES & HOSPITALS, BY REGION, 2019–2026 (USD MILLION) 166
9.3 HOME CARE SETTINGS/INDIVIDUALS 167
9.3.1 INCREASING PATIENT PREFERENCE FOR HOME-BASED SLEEP TESTS TO FUEL MARKET GROWTH 167
TABLE 85 SLEEP APNEA DEVICES MARKET FOR HOME CARE SETTINGS/INDIVIDUALS, BY REGION, 2019–2026 (USD MILLION) 168
10 SLEEP APNEA DEVICES MARKET, BY REGION 169
10.1 INTRODUCTION 170
10.2 NORTH AMERICA 170
FIGURE 35 NORTH AMERICA: SLEEP APNEA DEVICES MARKET SNAPSHOT 171
TABLE 86 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 172
TABLE 87 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 172
TABLE 88 NORTH AMERICA: SLEEP APNEA THERAPEUTIC DEVICES MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 172
TABLE 89 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 173
TABLE 90 NORTH AMERICA: FACIAL INTERFACES MARKET, BY TYPE,
2019–2026 (USD MILLION) 173
TABLE 91 NORTH AMERICA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 173
TABLE 92 NORTH AMERICA: ACCESSORIES MARKET, BY TYPE,
2019–2026 (USD MILLION) 174
TABLE 93 NORTH AMERICA: ORAL APPLIANCES MARKET, BY TYPE,
2019–2026 (USD MILLION) 174
TABLE 94 NORTH AMERICA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET,
BY PRODUCT, 2019–2026 (USD MILLION) 174
TABLE 95 NORTH AMERICA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 175
TABLE 96 NORTH AMERICA: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 175
TABLE 97 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 175
10.2.1 US 176
10.2.1.1 Availability of grants and funds and the increasing trend of home sleep testing are expected to drive market growth in the US during the forecast period 176
TABLE 98 KEY SLEEP APNEA PRODUCTS IN THE US 177
TABLE 99 US: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 178
TABLE 100 US: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 178
TABLE 101 US: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 178
TABLE 102 US: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 103 US: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 104 US: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 179
TABLE 105 US: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION) 180
TABLE 106 US: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 180
TABLE 107 US: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 180
TABLE 108 US: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 181
TABLE 109 US: SLEEP APNEA DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 181
10.2.2 CANADA 181
10.2.2.1 Rising number of research grants and health programs to drive market growth in Canada 181
TABLE 110 KEY SLEEP APNEA PRODUCTS IN CANADA 182
TABLE 111 CANADA: SLEEP APNEA DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 182
TABLE 112 CANADA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 183
TABLE 113 CANADA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 114 CANADA: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION) 183
TABLE 115 CANADA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 116 CANADA: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 117 CANADA: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION) 184
TABLE 118 CANADA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 185
TABLE 119 CANADA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 185
TABLE 120 CANADA: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 185
TABLE 121 CANADA: SLEEP APNEA DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 186
10.3 EUROPE 186
TABLE 122 EUROPE: SLEEP APNEA DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 187
TABLE 123 EUROPE: SLEEP APNEA DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 187
TABLE 124 EUROPE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 188
TABLE 125 EUROPE: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 188
TABLE 126 EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION) 188
TABLE 127 EUROPE: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 128 EUROPE: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 129 EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION) 189
TABLE 130 EUROPE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 190
TABLE 131 EUROPE: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 190
TABLE 132 EUROPE: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 190
TABLE 133 EUROPE: SLEEP APNEA DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 191
10.3.1 GERMANY 191
10.3.1.1 Prevalence of OSA in Germany is among the highest in Europe—
a key factor driving market growth 191
TABLE 134 KEY SLEEP APNEA PRODUCTS IN GERMANY 192
TABLE 135 GERMANY: SLEEP APNEA DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 192
TABLE 136 GERMANY: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 193
TABLE 137 GERMANY: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 193
TABLE 138 GERMANY: FACIAL INTERFACES MARKET, BY TYPE,
2019–2026 (USD MILLION) 193
TABLE 139 GERMANY: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 140 GERMANY: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 194
TABLE 141 GERMANY: ORAL APPLIANCES MARKET, BY TYPE,
2019–2026 (USD MILLION) 194
TABLE 142 GERMANY: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 195
TABLE 143 GERMANY: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 195
TABLE 144 GERMANY: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 195
TABLE 145 GERMANY: SLEEP APNEA DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 196
10.3.2 FRANCE 196
10.3.2.1 Rising geriatric population to increase the incidence of sleep apnea in France 196
TABLE 146 FRANCE: SLEEP APNEA DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 197
TABLE 147 FRANCE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 197
TABLE 148 FRANCE: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 197
TABLE 149 FRANCE: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION) 198
TABLE 150 FRANCE: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 198
TABLE 151 FRANCE: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 198
TABLE 152 FRANCE: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION) 199
TABLE 153 FRANCE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 199
TABLE 154 FRANCE: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 199
TABLE 155 FRANCE: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 200
TABLE 156 FRANCE: SLEEP APNEA DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 200
10.3.3 UK 200
10.3.3.1 Rising awareness initiatives and sleep service groups to support market growth in the UK 200
TABLE 157 UK: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 201
TABLE 158 UK: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 201
TABLE 159 UK: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 202
TABLE 160 UK: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION) 202
TABLE 161 UK: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 202
TABLE 162 UK: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 203
TABLE 163 UK: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION) 203
TABLE 164 UK: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 203
TABLE 165 UK: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 204
TABLE 166 UK: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 204
TABLE 167 UK: SLEEP APNEA DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 204
10.3.4 ITALY 205
10.3.4.1 High prevalence of sleep apnea and increasing awareness to drive market growth in Italy 205
TABLE 168 PREVALENCE OF OBSTRUCTIVE SLEEP APNEA FOR THE POPULATION IN ITALY, 2018 205
TABLE 169 ITALY: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 205
TABLE 170 ITALY: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 206
TABLE 171 ITALY: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 172 ITALY: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION) 206
TABLE 173 ITALY: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 207
TABLE 174 ITALY: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 207
TABLE 175 ITALY: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION) 207
TABLE 176 ITALY: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 208
TABLE 177 ITALY: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 208
TABLE 178 ITALY: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 208
TABLE 179 ITALY: SLEEP APNEA DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 209
10.3.5 SPAIN 209
10.3.5.1 Increasing initiatives for awareness by regional organizations are driving the market growth in Spain 209
TABLE 180 SPAIN: SLEEP APNEA DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 209
TABLE 181 SPAIN: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 210
TABLE 182 SPAIN: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 210
TABLE 183 SPAIN: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION) 210
TABLE 184 SPAIN: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 185 SPAIN: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 186 SPAIN: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION) 211
TABLE 187 SPAIN: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 212
TABLE 188 SPAIN: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 212
TABLE 189 SPAIN: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 212
TABLE 190 SPAIN: SLEEP APNEA DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 213
10.3.6 REST OF EUROPE 213
TABLE 191 ROE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 213
TABLE 192 ROE: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 214
TABLE 193 ROE: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 214
TABLE 194 ROE: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION) 214
TABLE 195 ROE: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 215
TABLE 196 ROE: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 215
TABLE 197 ROE: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION) 215
TABLE 198 ROE: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 216
TABLE 199 ROE: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 216
TABLE 200 ROE: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 216
TABLE 201 ROE: SLEEP APNEA DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 217
10.4 ASIA PACIFIC 217
FIGURE 36 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET SNAPSHOT 218
TABLE 202 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY COUNTRY,
2019–2026 (USD MILLION) 219
TABLE 203 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 219
TABLE 204 ASIA PACIFIC: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 219
TABLE 205 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 220
TABLE 206 ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE,
2019–2026 (USD MILLION) 220
TABLE 207 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 220
TABLE 208 ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 221
TABLE 209 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE,
2019–2026 (USD MILLION) 221
TABLE 210 ASIA PACIFIC: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 221
TABLE 211 ASIA PACIFIC: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 222
TABLE 212 ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 222
TABLE 213 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 222
10.4.1 JAPAN 223
10.4.1.1 Changing reimbursement scenario and increasing demand for cloud-connected sleep apnea therapeutic devices to drive market growth
in Japan 223
TABLE 214 JAPAN: SLEEP APNEA DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 224
TABLE 215 JAPAN: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 224
TABLE 216 JAPAN: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 224
TABLE 217 JAPAN: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION) 225
TABLE 218 JAPAN: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 225
TABLE 219 JAPAN: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 225
TABLE 220 JAPAN: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION) 226
TABLE 221 JAPAN: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 226
TABLE 222 JAPAN: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 226
TABLE 223 JAPAN: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 227
TABLE 224 JAPAN: SLEEP APNEA DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 227
10.4.2 CHINA 227
10.4.2.1 Growing adult obesity rates and expanding geriatric population to increase the prevalence of sleep apnea in China 227
TABLE 225 CHINA: SLEEP APNEA DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 228
TABLE 226 CHINA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 228
TABLE 227 CHINA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 229
TABLE 228 CHINA: FACIAL INTERFACES MARKET, BY TYPE, 2019–2026 (USD MILLION) 229
TABLE 229 CHINA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 229
TABLE 230 CHINA: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 230
TABLE 231 CHINA: ORAL APPLIANCES MARKET, BY TYPE, 2019–2026 (USD MILLION) 230
TABLE 232 CHINA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2019–2026 (USD MILLION) 230
TABLE 233 CHINA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 231
TABLE 234 CHINA: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 231
TABLE 235 CHINA: SLEEP APNEA DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 231
 
10.4.3 AUSTRALIA 232
10.4.3.1 High prevalence of sleep apnea and growing number of awareness programs to drive market growth in Australia 232
TABLE 236 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 233
TABLE 237 AUSTRALIA: SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 233
TABLE 238 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION) 233
TABLE 239 AUSTRALIA: FACIAL INTERFACES MARKET, BY TYPE,
2019–2026 (USD MILLION) 234
TABLE 240 AUSTRALIA: MASKS MARKET, BY TYPE, 2019–2026 (USD MILLION) 234
TABLE 241 AUSTRALIA: ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION) 234
TABLE 242 AUSTRALIA: ORAL APPLIANCES MARKET, BY TYPE,
2019–2026 (USD MILLION) 235
TABLE 243 AUSTRALIA: SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION) 235
TABLE 244 AUSTRALIA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 235
TABLE 245 AUSTRALIA: OXIMETERS MARKET, BY TYPE, 2019–2026 (USD MILLION) 236
TABLE 246 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY END USER,
2019–2026 (USD MILLION) 236

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127